Skip to main content
Clinical Trials/CTRI/2025/01/079146
CTRI/2025/01/079146
Completed
Phase 4

External oblique intercostal plane block versus Erector spinae plane block for post operative analgesia in open hepatopancreatic biliary surgeries- a randomized control trial

Institute of liver and biliary sciences1 site in 1 country60 target enrollmentStarted: February 5, 2025Last updated:

Overview

Phase
Phase 4
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
To compare the postoperative fentanyl

Overview

Brief Summary

Hypothesis; external oblique intercostal plane block is as effective as erector spinae plane block in providing analgesia in patients undergoing open hepatopancreatic biliary surgeries

Study population - 60 patients undergoing open hepatopancreatic biliary surgeries

Group A- 30 patients- USG guided External oblique intercostal plane block.

Group B- 30 patients- USG guided Erector spinae plane block.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age 18-60 years , undergoing open hepatopancreatic and biliary surgery, who give consent.

Exclusion Criteria

  • Patient refusal Infection at site of administration Allergy to local anaesthetics Insufficient comprehension of the use of Patient controlled Analgesia ( PCA) machine Coagulopathy and thrombocytopenia (Platelet count less than 80,000/ microL ).

Outcomes

Primary Outcomes

To compare the postoperative fentanyl

Time Frame: upto 24 hours in the post operative period

consumption at 24 hours between the external oblique intercostal plane block and Erector spinae plane block groups

Time Frame: upto 24 hours in the post operative period

Secondary Outcomes

  • To compare the intraoperative IV fentanyl requirements in both the groups.(To compare the postoperative pain using NRS in both the groups)

Investigators

Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Kiran Premraj

Institute of Liver and Biliary sciences

Study Sites (1)

Loading locations...

Similar Trials